Cite
Pre-treatment HIV-drug resistance associated with virologic outcome of first-line NNRTI-antiretroviral therapy: A cohort study in Kenya
MLA
Ingrid A. Beck, et al. “Pre-Treatment HIV-Drug Resistance Associated with Virologic Outcome of First-Line NNRTI-Antiretroviral Therapy: A Cohort Study in Kenya.” EClinicalMedicine, vol. 18, no., Jan. 2020. EBSCOhost, https://doi.org/10.1016/j.eclinm.2019.100239.
APA
Ingrid A. Beck, Molly Levine, Christine J. McGrath, Steve Bii, Ross S. Milne, James M. Kingoo, Isaac So, Nina Andersen, Sandra Dross, Robert W. Coombs, James Kiarie, Bhavna Chohan, Samah R. Sakr, Michael H. Chung, & Lisa M. Frenkel. (2020). Pre-treatment HIV-drug resistance associated with virologic outcome of first-line NNRTI-antiretroviral therapy: A cohort study in Kenya. EClinicalMedicine, 18. https://doi.org/10.1016/j.eclinm.2019.100239
Chicago
Ingrid A. Beck, Molly Levine, Christine J. McGrath, Steve Bii, Ross S. Milne, James M. Kingoo, Isaac So, et al. 2020. “Pre-Treatment HIV-Drug Resistance Associated with Virologic Outcome of First-Line NNRTI-Antiretroviral Therapy: A Cohort Study in Kenya.” EClinicalMedicine 18. doi:10.1016/j.eclinm.2019.100239.